Explore 3 Stock Ideas & Industry Insights Download Free Report

small-cap

Oncolytics Biotech: Pelareorep’s Clinical Progress Faces a Critical Funding Test

Oct 15, 2026 | Team Kalkine
Oncolytics Biotech: Pelareorep’s Clinical Progress Faces a Critical Funding Test
Image source: shutterstock

  • ONCY:NASDAQ
  • Investment Type
    Small-Cap
  • Risk Level
  • Action
  • Rec. Price (US$)

Oncolytics Biotech Inc

Oncolytics Biotech Inc (NASDAQ: ONCY) is a clinical-stage biopharmaceutical company developing pelareorep, an intravenous immunotherapy designed to activate immune responses and make tumors more susceptible to cancer treatments. Supported by encouraging findings across several cancer studies, the company is advancing pelareorep alongside chemotherapy and/or checkpoint inhibitors, primarily targeting metastatic gastrointestinal cancers..

Latest Business Development


Disclaimer-

The advice given by Kalkine Canada Advisory Services Inc. and provided on this website is general information only and it does not take into account your investment objectives, financial situation and the particular needs of any particular person. You should therefore consider whether the advice is appropriate to your investment objectives, financial situation and needs before acting upon it. You should seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) as necessary before acting on any advice. Not all investments are appropriate for all people. The website www.kalkine.ca is published by Kalkine Canada Advisory Services Inc. The link to our Terms & Conditions has been provided please go through them. On the date of publishing this report (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.

Past performance is not a reliable indicator of future performance.

Support

Hi! How can we help you today?

Loading…